An observational study on the timing of intubation and outcome in COVID-19 ARDS patients who were treated with high flow nasal oxygen prior to invasive mechanical ventilation: A time series analysis (InOutHFNO trial)

Background and Aims: Prolonged high flow nasal oxygen (HFNO) application might delay intubation and increase mortality in acute hypoxemic respiratory failure (AHRF) patients. Intubation in coronavirus disease 2019 (COVID-19) AHRF (CAHRF) patients 24 to 48 hours after HFNO initiation has been associ...

Full description

Bibliographic Details
Main Authors: Rupak Kundu, Sounak Ghosh, Subhash Todi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Indian Journal of Anaesthesia
Subjects:
Online Access:http://www.ijaweb.org/article.asp?issn=0019-5049;year=2023;volume=67;issue=5;spage=439;epage=444;aulast=Kundu
_version_ 1797775201986936832
author Rupak Kundu
Sounak Ghosh
Subhash Todi
author_facet Rupak Kundu
Sounak Ghosh
Subhash Todi
author_sort Rupak Kundu
collection DOAJ
description Background and Aims: Prolonged high flow nasal oxygen (HFNO) application might delay intubation and increase mortality in acute hypoxemic respiratory failure (AHRF) patients. Intubation in coronavirus disease 2019 (COVID-19) AHRF (CAHRF) patients 24 to 48 hours after HFNO initiation has been associated with increased mortality in previous studies. This cut-off period is variable in previous studies. A time series analysis could reflect more robust data on outcome in relation to HFNO duration before intubation in CAHRF. Methods: A retrospective study was conducted at 30-bedded ICU of a tertiary care teaching hospital from July 2020 to August 2021. The study cohort comprised 116 patients who required HFNO and were subsequently intubated following HFNO failure. A time series analysis of patient outcomes on each day of HFNO application prior to invasive mechanical ventilation (IMV) was done. Results: ICU and hospital mortality was 67.2%. Beyond day 4 of HFNO application, there was a trend towards increased risk-adjusted ICU and hospital mortality for each day delay in intubation of CAHRF patients on HFNO [OR 2.718; 95% CI 0.957–7.721; P 0.061]. This trend was maintained till day 8 of HFNO application, after which there was 100% mortality. Taking day four as a cut-off in the timeline of HFNO application, we have observed an absolute mortality benefit of 15% with early intubation despite a higher APACHE-IV score than the late intubation group. Conclusion: IMV beyond the 4th day of HFNO initiation in CAHRF patients increases mortality.
first_indexed 2024-03-12T22:32:19Z
format Article
id doaj.art-25319c511a7f454d9f0973d50bf7230e
institution Directory Open Access Journal
issn 0019-5049
0976-2817
language English
last_indexed 2024-03-12T22:32:19Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Anaesthesia
spelling doaj.art-25319c511a7f454d9f0973d50bf7230e2023-07-21T14:50:43ZengWolters Kluwer Medknow PublicationsIndian Journal of Anaesthesia0019-50490976-28172023-01-0167543944410.4103/ija.ija_672_22An observational study on the timing of intubation and outcome in COVID-19 ARDS patients who were treated with high flow nasal oxygen prior to invasive mechanical ventilation: A time series analysis (InOutHFNO trial)Rupak KunduSounak GhoshSubhash TodiBackground and Aims: Prolonged high flow nasal oxygen (HFNO) application might delay intubation and increase mortality in acute hypoxemic respiratory failure (AHRF) patients. Intubation in coronavirus disease 2019 (COVID-19) AHRF (CAHRF) patients 24 to 48 hours after HFNO initiation has been associated with increased mortality in previous studies. This cut-off period is variable in previous studies. A time series analysis could reflect more robust data on outcome in relation to HFNO duration before intubation in CAHRF. Methods: A retrospective study was conducted at 30-bedded ICU of a tertiary care teaching hospital from July 2020 to August 2021. The study cohort comprised 116 patients who required HFNO and were subsequently intubated following HFNO failure. A time series analysis of patient outcomes on each day of HFNO application prior to invasive mechanical ventilation (IMV) was done. Results: ICU and hospital mortality was 67.2%. Beyond day 4 of HFNO application, there was a trend towards increased risk-adjusted ICU and hospital mortality for each day delay in intubation of CAHRF patients on HFNO [OR 2.718; 95% CI 0.957–7.721; P 0.061]. This trend was maintained till day 8 of HFNO application, after which there was 100% mortality. Taking day four as a cut-off in the timeline of HFNO application, we have observed an absolute mortality benefit of 15% with early intubation despite a higher APACHE-IV score than the late intubation group. Conclusion: IMV beyond the 4th day of HFNO initiation in CAHRF patients increases mortality.http://www.ijaweb.org/article.asp?issn=0019-5049;year=2023;volume=67;issue=5;spage=439;epage=444;aulast=Kunducovid-19hfno failuremechanical ventilation
spellingShingle Rupak Kundu
Sounak Ghosh
Subhash Todi
An observational study on the timing of intubation and outcome in COVID-19 ARDS patients who were treated with high flow nasal oxygen prior to invasive mechanical ventilation: A time series analysis (InOutHFNO trial)
Indian Journal of Anaesthesia
covid-19
hfno failure
mechanical ventilation
title An observational study on the timing of intubation and outcome in COVID-19 ARDS patients who were treated with high flow nasal oxygen prior to invasive mechanical ventilation: A time series analysis (InOutHFNO trial)
title_full An observational study on the timing of intubation and outcome in COVID-19 ARDS patients who were treated with high flow nasal oxygen prior to invasive mechanical ventilation: A time series analysis (InOutHFNO trial)
title_fullStr An observational study on the timing of intubation and outcome in COVID-19 ARDS patients who were treated with high flow nasal oxygen prior to invasive mechanical ventilation: A time series analysis (InOutHFNO trial)
title_full_unstemmed An observational study on the timing of intubation and outcome in COVID-19 ARDS patients who were treated with high flow nasal oxygen prior to invasive mechanical ventilation: A time series analysis (InOutHFNO trial)
title_short An observational study on the timing of intubation and outcome in COVID-19 ARDS patients who were treated with high flow nasal oxygen prior to invasive mechanical ventilation: A time series analysis (InOutHFNO trial)
title_sort observational study on the timing of intubation and outcome in covid 19 ards patients who were treated with high flow nasal oxygen prior to invasive mechanical ventilation a time series analysis inouthfno trial
topic covid-19
hfno failure
mechanical ventilation
url http://www.ijaweb.org/article.asp?issn=0019-5049;year=2023;volume=67;issue=5;spage=439;epage=444;aulast=Kundu
work_keys_str_mv AT rupakkundu anobservationalstudyonthetimingofintubationandoutcomeincovid19ardspatientswhoweretreatedwithhighflownasaloxygenpriortoinvasivemechanicalventilationatimeseriesanalysisinouthfnotrial
AT sounakghosh anobservationalstudyonthetimingofintubationandoutcomeincovid19ardspatientswhoweretreatedwithhighflownasaloxygenpriortoinvasivemechanicalventilationatimeseriesanalysisinouthfnotrial
AT subhashtodi anobservationalstudyonthetimingofintubationandoutcomeincovid19ardspatientswhoweretreatedwithhighflownasaloxygenpriortoinvasivemechanicalventilationatimeseriesanalysisinouthfnotrial
AT rupakkundu observationalstudyonthetimingofintubationandoutcomeincovid19ardspatientswhoweretreatedwithhighflownasaloxygenpriortoinvasivemechanicalventilationatimeseriesanalysisinouthfnotrial
AT sounakghosh observationalstudyonthetimingofintubationandoutcomeincovid19ardspatientswhoweretreatedwithhighflownasaloxygenpriortoinvasivemechanicalventilationatimeseriesanalysisinouthfnotrial
AT subhashtodi observationalstudyonthetimingofintubationandoutcomeincovid19ardspatientswhoweretreatedwithhighflownasaloxygenpriortoinvasivemechanicalventilationatimeseriesanalysisinouthfnotrial